Search Results

240 results for MER

Which Coronavirus Stock Could Fetch Higher Returns?

By Sirisha Bhogaraju

This article will compare Pfizer, Moderna, and Novavax to see which of these coronavirus stocks will yield the highest returns.

Gilead Sciences Is a Strong Buy Despite What Its Detractors Might Say

By Louis Navellier and the InvestorPlace Research Staff

Gilead Sciences is donating 1.5 million doses of remdesivir, which has many analysts bullish on GILD stock now.

I Would Hope Inovio Isn’t Attracting ANY Serious Money

By Will Ashworth, InvestorPlace Contributor

A recent article wondered if the smart money preferred Ocugen or Inovio. I would hope neither INO stock or OCGN is getting any serious money.

Is Inovio Stock Still a Buy After Its Massive 150% Leap This Year?

By Tezcan Gecgil, InvestorPlace Contributor

Inovio is developing a potential vaccine for the coronavirus. If you can handle the volatility, it may be time to buy INO stock.

Germany Makes a $299 Million Bet on CureVac

By Will Ashworth, InvestorPlace Contributor

CureVac recently was awarded $299 million to support the development of its Covid-19 vaccine. What does this mean for CureVac stock?  

As Its Vaccine Dreams Fade, Inovio Stock Will Keep Retreating

By Vince Martin, InvestorPlace Contributor

INO stock has pulled back some 72% from its highs. But the fade makes sense, and even at a cheaper price the stock still looks…

7 A-Rated Stocks to Buy and Hold for Q2 and Beyond!

By Louis Navellier, Editor, Growth Investor

Sellers may be dominating the markets, which makes it all the more difficult to find A-rated stocks to buy. Don’t fret, I’ve found them for…

5 Easy Ways to Throw PG Stock in Your Cart

By Will Ashworth, InvestorPlace Contributor

PG stock has had a good year in 2013, but sometimes you’re better off with an ETF that holds the stock. Here are 5 ways…

Trade Options for Income

By Bryan Perry

This isn’t our parents’ stock market, thanks to the explosion of the derivatives markets during the past few decades that we can use to our…

The Stocks Hiding in AI’s “Magical Spaces”

By Eric Fry, Editor, Fry's Investment Report

Many investors are overlooking the companies that will find the “magical spaces” between existing technologies to create revolutionary industrial processes, commercial innovations, and scientific discoveries.…

The Painful Mistake After Finding a 10-Bagger

By Luis Hernandez, Editor in Chief

AI is moving too quickly. The potential rewards are becoming too large. And the divide between the companies benefiting from this revolution and those left…

3 Cosmetics Stocks to Freshen Up Your Holdings

By Tezcan Gecgil, InvestorPlace Contributor

Here are three solid cosmetic stocks for long-term portfolios. They are likely to have stable growth in the years to come.

Gilead Stock Isn’t Worth Chasing Now Despite Recent Remdesivir Success

By Luke Lango, InvestorPlace Senior Investment Analyst

Gilead’s remdesivir appears to be an effective treatment against the coronavirus. Still, I wouldn’t chase GILD stock now.

Beauty Stocks: 3 to Buy, 3 to Leave

By Susan J. Aluise, Aviation, Auto & Transportation Writer

This month has been wild for beauty shares. It’s time to turn to the Socratic principle: Question everything.

The InvestorPlace Q&A: Embrace the Food Revolution With the ANEW ETF

By Jessica Loder, InvestorPlace Assistant Editor

The ANEW ETF is investing in companies pushing the boundaries of technology when it comes to feeding the planet. Here’s what you need to know.

How TradeSmithGPT Can Turn Good Calls Into Great Ones 

By Thomas Yeung, CFA, InvestorPlace Markets Analyst

Complex systems designed to sniff out moves in the market have only gotten better with time. And now, we’re making our corporate partner TradeSmith’s most…

AI Spending Just Revealed a $7,000 Gap Between Winners and Losers

By Luke Lango, InvestorPlace Senior Investment Analyst

Top agentic AI adopters now spend $7,400 per employee monthly, versus just $12 for the average firm. Here’s why that gap points to an AI…

5 Rational Biotech Stocks to Buy

By Neil George

These biotech stocks allow you to profit off the innovations that are giving us longer, healthier lives through the companies that make them.

7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine

By Louis Navellier and the InvestorPlace Research Staff

Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.

7 Cybersecurity Stocks to Buy Now

By Will Ashworth, InvestorPlace Contributor

The cybersecurity market is said to be $100 billion on a global basis. Here are seven cybersecurity stocks to buy now.

The 10 Best Investments for the Next 10 Years

By Will Ashworth, InvestorPlace Contributor

This list of the 10 best investments for the next 10 years includes a little bit of everything — stocks, ETFs, mutual funds and more.

7 Top Robinhood Stocks to Buy Heading Into Q4

By Faisal Humayun, InvestorPlace Contributor

These 7 Robinhood stocks are positioned for a rally in Q4 2021. Check out these non-speculative Robinhood stocks to buy for near-term gains.

4 Catalysts That Could Put Space Stocks Back in Orbit in 2026

By Luke Lango, InvestorPlace Senior Investment Analyst

Space stocks have four new catalysts in 2026 – policy execution, SpaceX validation, orbital compute, and a collapsing launch cost curve.

10 Stocks to Buy Heading Into the Teeth of Winter

By Will Ashworth, InvestorPlace Contributor

The forecast for winter in a large part of the country calls for warmer than usual temperatures. Here are 10 stocks to buy to benefit.

7 – 10 of 240 results